The DKMS-BMST Thalassemia program: Description, scope and impact
Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is the only established curative therapy for thalassemia. However, access to transplantation is constrained in limited-resource settings. Human leukocyte antigen (HLA) typing of patients and potential donors is one relevant barrier to al...
Saved in:
Main Authors: | , , , , , , , , |
---|---|
Format: | Book |
Published: |
Elsevier,
2023-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Internet
Connect to this object online.3rd Floor Main Library
Call Number: |
A1234.567 |
---|---|
Copy 1 | Available |